RDUS - Radius Pharmaceuticals Total Debt to Capital

The price chart for Radius Recycling, Inc. (RDUS) demonstrates the 1.13 level, while the business relies on outsourced drug synthesis via US CMO facilities. Simultaneously, Radius Recycling, Inc. (RDUS) is developing partnerships with municipal services and plants for metal recycling. The current trajectory focuses on implementing AI-driven sorting and equipment modernization, replacing the search for new pharmaceutical formulas with the applied upgrading of its technical base.

To minimize fundamental risks, investors select assets with controlled leverage, where the ratio of total liabilities to equity determines the business's dependence on borrowed funds. The current value of 1.13 reflects the financial stability of Radius Recycling, Inc. (RDUS) during a period of liquidity austerity and a pivot away from mergers, making the business's leverage ratio a key indicator of the company's survivability under cyclical pressure.